Welke behandelingen zijn er en wat past bij u? Bij u is acute myeloïde leukemie (AML) vastgesteld. Dat kan betekenen dat er veel op u en uw naasten afkomt. Uw arts geeft u zoveel mogelijk informatie over wat u kunt verwachten. Deze brochure geeft een overzicht van die informatie: wat is AML, welke behandelingen zijn er…
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma Video Abstract https://vimeo.com/528564038 ePrint Author(s): Robin K. Kelley et al. Published: May 18, 2020 Copyright: The Author(s) 2020. By accessing this ePrint you agree to our terms and conditions (click to view) By accessing this content you are agreeing to the following terms and conditions,…
A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP Coppo et al. Blood 2021; 137(6): 733–742. Select your desired language: English German | Deutsch Spanish | Español French | Français Italian | Italiano Japanese | 日本語 English Access ePrint German | Deutsch Available Soon Spanish | Español Available Soon French…
Biomarkers (Subtítulos en español) Citation: Chasing The Sun – ID Week 2020Published: October 2020 (online)Copyright: © 2020 Infectious Diseases Society of America (IDSA). All Rights Reserved. Site provided by Springer Healthcare. Part of the Springer Nature Group. Privacy Policy
Clinical Electroencephalography 2. Epilessia nell’adulto Editor(s): Oriano MecarelliCopyright: © 2020 Springer Healthcare Italia S.r.l. By accessing this ePrint you agree to our terms and conditions By accessing this content you are agreeing to the following terms and conditions, and certifying that the content provided is for your personal use only. The modification, adaptation, manipulation, transformation,…
Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for nonmetastatic castration-resistant prostate cancer (nmCRPC) Abstract Poster Presentation Poster Authors: Karim Fizazi, Neal D. Shore, Teuvo Tammela, Albertas Ulys, Egils Vjaters, Sergey Polyakov, Mindaugas Jievaltas, Murilo Luz, Boris Alekseev, Iris Kuss, Marie-Aude Le Berre, Oana Petrenciuc,…
141 – Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial Abstract Presentation Abstract View author list and disclosures Author(s): Francesca Gay, MD, Pellegrino Musto, Delia Rota Scalabrini*, Monica Galli*, Angelo Belotti, MD*, Elena Zamagni, MD*, Luca Bertamini, MD*, Renato Zambello*, Micol Quaresima*, Giovanni De Sabbata*, Giuseppe Pietrantuono*, Mattia D’Agostino,…
1187 – Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel) Abstract Presentation Slides Abstract View author list and disclosures Author(s): Caron Jacobson, MD, MMSc1, Frederick L. Locke, MD2, Armin Ghobadi, MD3, David B. Miklos, MD, PhD4, Lazaros J. Lekakis, MD5*, Olalekan O.…